Dr Reddys
A brief history of Indian companies' tryst with class action suits
BSE Healthcare index hits record high; Laurus Labs, Dr Reddy's at new highs
Sensex ends 134 pts lower, Nifty settles at 11,505; Nifty Pharma jumps 5%
Russia ropes in Dr Reddy's to sell 100 mn Covid-19 vaccine doses; stk up 4%
New launches, patents: Multiple catalysts for Dr Reddy's US business

Cipla tweaks management structure to mobilise second level of executives
TCS, Infosys, and Dr Reddy's shares hit fresh record highs
India's coronavirus drug market set for price war as firms ready launches
Covid-19 crisis: Made-in-India remdesivir may come by end of June
Revised Wockhardt deal boosts prospects of Dr Reddy's India business

Dr Reddy's Q4 PBT up 22% at Rs 714 cr on buoyant US, European business
Dr Reddy's gets USFDA inspection closure report fo Srikakulam unit
Dr Reddy's Labs hits over 4-year high, surges 62% from March low
Dr Reddy's board approves borrowing of Rs 2,000 cr through multiple routes
USFDA seeks voluntary action at Dr Reddy's Andhra Pradesh facility
Diabetes to be our focus in India, US: Wockhardt's Habil Khorakiwala
New launches, regulatory go-ahead key triggers for Dr Reddy's
Top headlines: Air India's 100% stake sale; 1,000 frauds in 5 years at UCBs
Stock recommendation from Prabhudas Lilladher: Buy Dr Reddy's, GAIL
Dr Reddy's falls 5% as rival firm beats Co to US FDA approval for EluRyng